1
/
of
1
Elabscience
SKU:PKSH033633
Recombinant Human IL-1RA/IL1RN Protein
Recombinant Human IL-1RA/IL1RN Protein
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IL-1RA/IL1RN Protein, a cutting-edge biotechnological advancement in the field of immunology. This meticulously engineered protein is derived from human Interleukin-1 Receptor Antagonist (IL-1RA), also known as IL1RN, and offers a multitude of therapeutic applications.
The Recombinant Human IL-1RA/IL1RN Protein is produced through a state-of-the-art recombinant DNA technology, ensuring utmost purity and potency. This protein exhibits a high affinity for the Interleukin-1 receptor, effectively inhibiting the binding of IL-1α and IL-1β to their receptor sites. By doing so, it effectively neutralizes the pro-inflammatory effects of these cytokines, thereby mitigating the associated inflammatory responses.
This groundbreaking protein holds immense promise in the treatment of various inflammatory disorders, including rheumatoid arthritis, osteoarthritis, and systemic juvenile idiopathic arthritis. Its ability to modulate the immune response and suppress inflammation makes it an invaluable tool in managing these debilitating conditions.
Furthermore, the Recombinant Human IL-1RA/IL1RN Protein has shown remarkable potential in the field of regenerative medicine. Its anti-inflammatory properties have been observed to promote tissue repair and regeneration, making it an attractive candidate for therapeutic interventions in tissue engineering and wound healing.
In addition to its therapeutic applications, this protein also serves as a valuable research tool for scientists and clinicians alike. Its ability to selectively inhibit IL-1 signaling pathways enables the elucidation of complex immunological mechanisms, paving the way for novel discoveries and advancements in the field.
The Recombinant Human IL-1RA/IL1RN Protein is meticulously manufactured in compliance with stringent quality control measures, ensuring its safety, purity, and consistency. It is available in various formats, including lyophilized powder and liquid formulations, to cater to diverse research and clinical requirements.
In conclusion, the Recombinant Human IL-1RA/IL1RN Protein represents a groundbreaking advancement in immunological research and therapeutic interventions. Its ability to neutralize pro-inflammatory cytokines and modulate immune responses holds immense potential in the treatment of inflammatory disorders and regenerative medicine. With its exceptional purity and potency, this protein is poised to revolutionize the field and contribute to the betterment of human health.
The Recombinant Human IL-1RA/IL1RN Protein is produced through a state-of-the-art recombinant DNA technology, ensuring utmost purity and potency. This protein exhibits a high affinity for the Interleukin-1 receptor, effectively inhibiting the binding of IL-1α and IL-1β to their receptor sites. By doing so, it effectively neutralizes the pro-inflammatory effects of these cytokines, thereby mitigating the associated inflammatory responses.
This groundbreaking protein holds immense promise in the treatment of various inflammatory disorders, including rheumatoid arthritis, osteoarthritis, and systemic juvenile idiopathic arthritis. Its ability to modulate the immune response and suppress inflammation makes it an invaluable tool in managing these debilitating conditions.
Furthermore, the Recombinant Human IL-1RA/IL1RN Protein has shown remarkable potential in the field of regenerative medicine. Its anti-inflammatory properties have been observed to promote tissue repair and regeneration, making it an attractive candidate for therapeutic interventions in tissue engineering and wound healing.
In addition to its therapeutic applications, this protein also serves as a valuable research tool for scientists and clinicians alike. Its ability to selectively inhibit IL-1 signaling pathways enables the elucidation of complex immunological mechanisms, paving the way for novel discoveries and advancements in the field.
The Recombinant Human IL-1RA/IL1RN Protein is meticulously manufactured in compliance with stringent quality control measures, ensuring its safety, purity, and consistency. It is available in various formats, including lyophilized powder and liquid formulations, to cater to diverse research and clinical requirements.
In conclusion, the Recombinant Human IL-1RA/IL1RN Protein represents a groundbreaking advancement in immunological research and therapeutic interventions. Its ability to neutralize pro-inflammatory cytokines and modulate immune responses holds immense potential in the treatment of inflammatory disorders and regenerative medicine. With its exceptional purity and potency, this protein is poised to revolutionize the field and contribute to the betterment of human health.
Share
